A Phase 1, Single-Center, Single-Blind, Placebo and Propofol Controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous (IV) Infusion Doses of ABP-700

Completed

• Conditions: anesthesia; Not applicable

• Registration Number: NL-OMON41980
• Lead Sponsor: Annovation Biopharma, Inc. (a wholly owned subsidiary of The Medicines Company, Inc.)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 72

Inclusion Criteria

Healthy adult men and/or women between 18 and 45 years of age (inclusive)

Exclusion Criteria

Clinical significant abnormalities at medical research

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Safety, PK and PD.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable.</p><br>